Clinical Roundup Cell Painting identifies flavonoids that are toxic to bladder cancer cells May 23, 2025Vol.51 No.20
Clinical Roundup Wistar scientists uncover new viral mechanism for evading immunity, identifying a new drug target May 23, 2025Vol.51 No.20
Clinical Roundup Common antidepressants could help the immune system fight cancer, UCLA study finds May 23, 2025Vol.51 No.20
Clinical Roundup Mayo Clinic researchers develop first salivary gland regenerative biobank to combat chronic dry mouth May 23, 2025Vol.51 No.20
Drugs & Targets FDA grants accelerated approval to avutometinib + defactinib for KRAS-mutated recurrent low-grade serous ovarian cancer May 23, 2025Vol.51 No.20
Capitol Hill Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFsTo avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges May 16, 2025Vol.51 No.19By Jacquelyn Cobb and Claire Marie Porter
Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reducedNCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.” May 16, 2025Vol.51 No.19By Jacquelyn Cobb
Cancer Policy Senate Democratic minority report: Trump cuts cancer research by 31% May 16, 2025Vol.51 No.19By Claire Marie Porter
Cancer Policy Executive order sets drug price targets for most-favored-nations May 16, 2025Vol.51 No.19By Jacquelyn Cobb
